Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Cocrystal Pharma Inc (COCP)

25 + Investors. Track Smart Money conviction in COCP. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -1
Streak
1Q ▼
Buyers last Q
50%

Smart Money Signals — COCP

Based on 25 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their COCP positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (96% of max)

96% of all-time peak
25 hedge funds hold COCP right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +9% more funds vs a year ago

fund count last 6Q
+2 new funds entered over the past year (+9% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 50% buying

10 buying10 selling
Last quarter: 10 funds bought or added vs 10 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~4 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 1 → 4 → 6 → 4. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

44% of holders stayed for 2+ years

44% conviction (2yr+) 28% medium 28% new
11 out of 25 hedge funds have held COCP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +1%, value -18%

Value
-18%
Shares
+0%
Last quarter: funds added +1% more shares while total portfolio value only changed -18%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~4 new funds/quarter

2 → 1 → 4 → 6 → 4 new funds/Q
New funds entering each quarter: 1 → 4 → 6 → 4. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Deep conviction — 48% of holders stayed 2+ years

48% veterans 20% 1-2yr 32% new
Of 25 current holders: 12 (48%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.

Strong quality — 24% AUM from major funds

24% from top-100 AUM funds
11 of 25 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.9
out of 10
Low Exit Risk
Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — COCP

In 2026 Q1, 10 hedge funds were net buyers of COCP (4 opened a new position, 6 added to an existing one), while 10 reduced or exited (5 trimmed, 5 sold completely) — a 50% buyer ratio, indicating a slight buying edge. 24% of total institutional value in COCP is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -1 funds (more exits than new entries). Total institutional holders: 25.

Hedge Fund Ownership: COCP

How many hedge funds hold COCP — quarterly history vs. share price
Quarterly hedge fund ownership of COCP vs. share price

Market Analysis: COCP

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: COCP

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Cocrystal Pharma Inc (COCP) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much COCP has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 79d ago
COCP
-4.0%
XLV
+2.8%

COCP outperformed XLV by -6.8% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 34d ago
COCP
-19.2%
XLV
+3.9%

Since the filing became public, COCP outperformed XLV by -23.1% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

5 top-rated funds 0 high-conviction
Consensus
3.4
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: COCP
25 + Investors

Track Smart Money conviction in COCP. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 25 26 -3.85%
13F Shares 776K 771K 0.73%
Total Value $771K $943K -18.27%
New Positions 4 6 -2
Increased Positions 6 4 +2
Closed Positions 5 1 +4
Reduced Positions 5 9 -4
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: COCP

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

25 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in COCP. Verified SEC 13F-HR filings.

QUARTER:
Top 21 COCP holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 T3 Companies, LLC 0.07% 51,500 $52K
2 Two Sigma Securities, LLC 0.00% 15,255 $15K
3 XTX Topco Ltd 0.00% 36,031 $36K
4 Parallel Advisors, LLC 0.00% 12,569 $13K
5 Renaissance Technologies LLC 0.00% 123,928 $125K
6 Clean Yield Group 0.00% 418
7 Tower Research Capital LLC (TRC) 0.00% 4,248 $4K
8 Neuberger Berman Group LLC 0.00% 31,886 $32K
9 Nvwm, LLC 0.00% 84
10 Vanguard Fiduciary Trust Co 0.00% 24,016 $24K
11 Vanguard Capital Management LLC 0.00% 239,971 $242K
12 Jane Street Group, LLC 0.00% 12,711 $13K
13 MAI Capital Management 0.00% 237
14 Wells Fargo & Company/Mn 0.00% 7,039 $7K
15 BlackRock, Inc. 0.00% 73,746 $74K
16 SBI Securities Co., Ltd. 0.00% 33
17 UBS Group AG 0.00% 4,644 $5K
18 Northwestern Mutual Wealth Management Co 0.00% 817
19 Morgan Stanley 0.00% 948
20 Fmr LLC 0.00% 334
21 Citigroup Inc 0.00% 1
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Cocrystal Pharma Inc (COCP)

What does the Smart Money Trend signal show for COCP?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their COCP positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for COCP?

Slight buying edge — 50% buying: Last quarter: 10 funds bought or added vs 10 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for COCP holders?

Strong quality — 24% AUM from major funds: 11 of 25 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held COCP?

44% of holders stayed for 2+ years: 11 out of 25 hedge funds have held COCP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Cocrystal Pharma Inc (COCP) following the 2026 Q1 hedge fund 13F filings?

As of today, COCP has moved -19.2% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of -23.1%. Since the quarter end (March 31, 2026), COCP has gained -4.0% vs +2.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →